Modification of the incidence of drug-associated symmetrical peripheral neuropathy by host and disease factors in the HIV outpatient study cohort.

KA, Lichtenstein; C, Armon; A, Baron; AC, Moorman; KC, Wood; SD, Holmberg

doi:10.1086/426076

Public

Modification of the incidence of drug-associated symmetrical peripheral neuropathy by host and disease factors in the HIV outpatient study cohort.

Shared by NobleBlocks on Dec 6, 2004 • 12:00 AM UTC

Authors:

Lichtenstein KA

Armon C

Baron A

Abstract

Background We sought to identify factors associated with the clinical diagnosis of symmetrical peripheral neuropathy (SPN) during the era of highly active antiretroviral therapy (HAART) in a retrospective, longitudinal cohort analysis.Methods Patients infected with human immunodeficiency virus type ...

Discussions